Heron Therapeutics, Inc. (HRTX)

Oncology Corporate Profile

Stock Performance

21.4100
-0.2500

HQ Location

123 Saginaw Drive
Redwood City, CA 94063

Company Description

Heron Therapeutics, Inc. is a biotechnology company using its proprietary technology and innovative efforts to develop products to address unmet medical needs. The Company's proprietary Biochronomer drug delivery technology is designed to improve the therapeutic profile of injectable pharmaceuticals. The Company's product development efforts focus on identifying current therapies with the potential to be reformulated to expand or extend therapeutic effect or duration of action, minimize drawbacks or to apply new delivery methods.

Website: http://www.herontx.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
SustolĀ®granisetron injection, extended releaseVarious cancer typesIII

View additional information on product candidates here »

Source: http://www.herontx.com/

Recent News Headlines

6/24/2017 12:18 pm

6/24/2017 12:18 pm

6/24/2017 12:18 pm

6/24/2017 12:18 pm

6/20/2017 06:19 am

6/20/2017 06:19 am

6/20/2017 06:19 am

6/11/2017 12:18 pm

5/30/2017 12:18 pm

5/30/2017 12:18 pm

5/26/2017 06:18 am

5/26/2017 06:18 am

5/26/2017 06:18 am

5/12/2017 12:18 pm

5/11/2017 06:18 am

5/10/2017 06:18 am

5/9/2017 12:18 pm

5/9/2017 12:18 pm

5/9/2017 12:18 pm

5/1/2017 06:18 am

5/1/2017 06:18 am

4/24/2017 12:18 pm

4/24/2017 12:18 pm

Heron Therapeutics to Present at the 16th Annual Needham Healthcare Conference

3/28/2017 08:02 pm

[Business Wire] - Heron Therapeutics, Inc. , a commercial-stage biotechnology company focused on developing novel best-in-class treatment solutions to address some of the biggest unmet patient needs, announced that Barry D.